Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30
Closed -$1.75K 5589
2023
Q1
$1.75K Hold
30
﹤0.01% 5446
2022
Q4
$1.07K Hold
30
﹤0.01% 5636
2022
Q3
$2K Hold
30
﹤0.01% 5698
2022
Q2
$4K Hold
30
﹤0.01% 5696
2022
Q1
$11K Hold
30
﹤0.01% 5630
2021
Q4
$9K Hold
30
﹤0.01% 5614
2021
Q3
$18K Hold
30
﹤0.01% 5407
2021
Q2
$31K Buy
30
+19
+173% +$22.1K ﹤0.01% 5243
2021
Q1
$15K Hold
11
﹤0.01% 5057
2020
Q4
$13K Hold
11
﹤0.01% 4826
2020
Q3
$13K Hold
11
﹤0.01% 4773
2020
Q2
$11K Buy
+11
New +$12.2K ﹤0.01% 4771

Other funds holding PHGE

BlackRock's PHGE Position: Q2 2023 in Review

BlackRock sold out of BiomX (PHGE) in Q2 2023, closing a stake of 30 shares — an estimated $1.75K sold.

BlackRock first reported a position in PHGE in Q2 2020 and held it in 12 quarters. The position peaked at $31K in Q2 2021. 9 funds tracked by Wall St. Rank hold PHGE as of Q2 2023.

  • BlackRock reported no remaining BiomX position as of Q2 2023 after selling out during the quarter.
  • BlackRock sold 30 BiomX shares in Q2 2023, an estimated $1.75K.
  • BlackRock first reported a position in BiomX in Q2 2020 and held it in 12 quarters.
  • BlackRock's BiomX position peaked at $31K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held BiomX as of Q2 2023.

Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.